Top American pharmaceutical firm Amgen (AMGN) on Monday unwrapped AmgenNow, its new direct-to-consumer platform. It kicked off the launch with a 60% discount on its popular cholesterol-reducing injection, Repatha. However, investors appear unimpresse... [2520 chars].. reed more
